Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
Despite the significant progress of modern anticancer therapies, multiple myeloma (MM) is still incurable for the majority of patients. Following almost three decades of development, chimeric antigen receptor (CAR) T-cell therapy now has the opportunity to revolutionize the treatment landscape and m...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2020-04-01
|
| Schriftenreihe: | Cells |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2073-4409/9/4/983 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|